Replication of human papillomavirus in culture

Methods in Molecular Biology

Volumn 1249, Issue , 2015, Pages 39-52

  Ryndock, Eric J ^a   Biryukov, Jennifer ^a   Meyers, Craig ^a  

^a NONE

Author keywords

Capsid; Differentiation; Disulfide bond; HPV; Viral maturation

Indexed keywords

CAPSID PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONFORMATIONAL TRANSITION; DISULFIDE BOND; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CULTURE; VIRUS GENOME; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS REPLICATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; MIRIDAE; PAPILLOMAVIRIDAE;

EID: 84921778456     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2013-6_3     Document Type: Article

References (80)

1. de Villiers EM et al (2004) Classifi cation of papillomaviruses. Virology 324(1):17–27
2. Longworth MS, Laimins LA (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68(2):362–372
3. Madsen BS et al (2008) Risk factors for invasive squamous cell carcinoma of the vulva and vagina–population-based case-control study in Denmark. Int J Cancer 122(12):2827–2834
4. D’Souza G et al (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19):1944–1956
5. Zheng ZM, Baker CC (2006) Papillomavirus genome structure, expression, and posttranscriptional regulation. Front Biosci 11: 2286–2302
6. Meyers C et al (1992) Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257(5072): 971–973
7. Roberts S et al (1994) Mutational analysis of human papillomavirus E4 proteins: identifi cation of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J Virol 68(10): 6432–6445
8. Bedell MA et al (1991) Amplifi cation of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol 65(5): 2254–2260
9. Kirnbauer R et al (1992) Papillomavirus L1 major capsid protein self-assembles into viruslike particles that are highly immunogenic. Proc Natl Acad Sci U S A 89(24):12180–12184
10. Kirnbauer R et al (1993) Effi cient self-assembly of human papillomavirus type 16L1 and L1-L2 into virus-like particles. J Virol 67(12): 6929–6936
11. Rose RC et al (1993) Expression of human papillomavirus type 11L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol 67(4):1936–1944
12. Hagensee ME et al (1994) Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J Virol 68(7): 4503–4505
13. Hagensee ME, Yaegashi N, Galloway DA (1993) Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol 67(1):315–322
14. Chen XS et al (2000) Structure of small viruslike particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 5(3): 557–567
15. Zhang W et al (1998) Expression of human papillomavirus type 16L1 protein in Escherichia coli: denaturation, renaturation, and selfassembly of virus-like particles in vitro. Virology 243(2):423–431
16. Buck CB et al (2005) Maturation of papillomavirus capsids. J Virol 79(5):2839–2846
17. Gambhira R et al (2007) A protective and broadly cross-neutralizing epitope of human papillomavirus L2. J Virol 81(24): 13927–13931
18. Culp TD, Christensen ND (2004) Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology 319(1):152–161
19. Pyeon D, Lambert PF, Ahlquist P (2005) Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc Natl Acad Sci U S A 102(26):9311–9316
20. Meyers C, Mayer TJ, Ozbun MA (1997) Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J Virol 71(10):7381–7386
21. McLaughlin-Drubin ME, Christensen ND, Meyers C (2004) Propagation, infection, and neutralization of authentic HPV16 virus. Virology 322(2):213–219
22. McLaughlin-Drubin ME et al (2003) Human papillomavirus type 45 propagation, infection, and neutralization. Virology 312(1):1–7
23. Gu W et al (2004) tRNASer(CGA) differentially regulates expression of wild-type and codon-modifi ed papillomavirus L1 genes. Nucleic Acids Res 32(15):4448–4461
24. McLaughlin-Drubin ME, Meyers C (2005) Propagation of infectious, high-risk HPV in organotypic “raft” culture. Methods Mol Med 119:171–186
25. Howett MK, Christensen ND, Kreider JW (1997) Tissue xenografts as a model system for study of the pathogenesis of papillomaviruses. Clin Dermatol 15(2):229–236
26. Moriyama T, Sorokin A (2009) BK virus (BKV): infection, propagation, quantitation, purifi cation, labeling, and analysis of cell entry. Curr Protoc Cell Biol Chapter 26:Unit 26 2
27. Leibowitz J, Kaufman G, Liu P (2011) Coronaviruses: propagation, quantifi cation, storage, and construction of recombinant mouse hepatitis virus. Curr Protoc Microbiol 2011. Chapter 15:Unit 15E 1
28. Yi M (2010) Hepatitis C virus: propagation, quantifi cation, and storage. Curr Protoc Microbiol. Chapter 15:Unit 15D 1
29. Bowser BS et al (2011) Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus. Virus Res 160(1–2):246–255
30. Chen HS et al (2010) Study of infectious virus production from HPV18/16 capsid chimeras. Virology 405(2):289–299
31. Chen HS et al (2011) Papillomavirus capsid proteins mutually impact structure. Virology 412(2):378–383
32. Conway MJ et al (2009) Overlapping and independent structural roles for human papillomavirus type 16L2 conserved cysteines. Virology 393(2):295–303
33. Conway MJ et al (2011) Differentiationdependent interpentameric disulfi de bond stabilizes native human papillomavirus type 16. PLoS One 6(7):e22427
34. Hummel M, Hudson JB, Laimins LA (1992) Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol 66(10):6070–6080
35. Grassmann K et al (1996) Identifi cation of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J Virol 70(4):2339–2349
36. Ozbun MA, Meyers C (1997) Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J Virol 71(7):5161–5172
37. Hirochika H, Broker TR, Chow LT (1987) Enhancers and trans-acting E2 transcriptional factors of papillomaviruses. J Virol 61(8): 2599–2606
38. Gloss B, Bernard HU (1990) The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol 64(11):5577–5584
39. Romanczuk H, Thierry F, Howley PM (1990) Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 64(6):2849–2859
40. Kyo S, Tam A, Laimins LA (1995) Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology 211(1):184–197
41. Kanaya T, Kyo S, Laimins LA (1997) The 5' region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology 237(1): 159–169
42. Cumming RC et al (2004) Protein disulfi de bond formation in the cytoplasm during oxidative stress. J Biol Chem 279(21):21749–21758
43. Wang X et al (2011) Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol 85(16):8080–8092
44. Bodily JM, Meyers C (2005) Genetic analysis of the human papillomavirus type 31 differentiation- dependent late promoter. J Virol 79(6):3309–3321
45. Bodily JM, Alam S, Meyers C (2006) Regulation of human papillomavirus type 31 late promoter activation and genome amplifi cation by protein kinase C. Virology 348(2): 328–340
46. Joshi A, Nagashima K, Freed EO (2006) Mutation of dileucine-like motifs in the human immunodefi ciency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gagmembrane binding, and virion maturation. J Virol 80(16):7939–7951
47. Perez-Berna AJ et al (2012) The role of capsid maturation on adenovirus priming for sequential uncoating. J Biol Chem 287(37):31582–31595
48. Hanslip SJ et al (2008) Intrinsic fl uorescence as an analytical probe of virus-like particle assembly and maturation. Biochem Biophys Res Commun 375(3):351–355
49. Conway MJ et al (2009) Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol 83(20): 10515–10526
50. Kennedy IM, Haddow JK, Clements JB (1991) A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J Virol 65(4): 2093–2097
51. Sokolowski M et al (1998) mRNA instability elements in the human papillomavirus type 16L2 coding region. J Virol 72(2):1504–1515
52. Zhao KN et al (2005) Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo. Mol Cell Biol 25(19):8643–8655
53. Bishop B et al (2007) Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specifi city of neutralizing monoclonal antibodies. J Biol Chem 282(43):31803–31811
54. Christensen ND, Kreider JW (1990) Antibodymediated neutralization in vivo of infectious papillomaviruses. J Virol 64(7):3151–3156
55. Wolf M et al (2010) Subunit interactions in bovine papillomavirus. Proc Natl Acad Sci U S A 107(14):6298–6303
56. Modis Y, Trus BL, Harrison SC (2002) Atomic model of the papillomavirus capsid. EMBO J 21(18):4754–4762
57. Ishii Y, Tanaka K, Kanda T (2003) Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids. Virology 308(1):128–136
58. Sapp M et al (1998) Papillomavirus assembly requires trimerization of the major capsid protein by disulfi des between two highly conserved cysteines. J Virol 72(7):6186–6189
59. Holmgren SC et al (2005) The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J Virol 79(7):3938–3948
60. Fey SJ et al (1989) Demonstration of in vitro synthesis of human papilloma viral proteins from hand and foot warts. J Invest Dermatol 92(6):817–824
61. Larsen PM, Storgaard L, Fey SJ (1987) Proteins present in bovine papillomavirus particles. J Virol 61(11):3596–3601
62. Buck CB et al (2008) Arrangement of L2 within the papillomavirus capsid. J Virol 82(11):5190–5197
63. Roden RB et al (1996) In vitro generation and type-specifi c neutralization of a human papillomavirus type 16 virion pseudotype. J Virol 70(9):5875–5883
64. Volpers C et al (1994) Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200(2):504–512
65. Rippe RA, Meinke WJ (1989) Identifi cation and characterization of the BPV-2L2 protein. Virology 171(1):298–301
66. Fligge C et al (2001) DNA-induced structural changes in the papillomavirus capsid. J Virol 75(16):7727–7731
67. Fay A et al (2004) The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding. J Virol 78(24):13447–13454
68. Bordeaux J et al (2006) The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA. J Virol 80(16):8259–8262
69. Gornemann J et al (2002) Interaction of human papillomavirus type 16L2 with cellular proteins: identifi cation of novel nuclear bodyassociated proteins. Virology 303(1):69–78
70. Kamper N et al (2006) A membranedestabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 80(2):759–768
71. Kawana K et al (1998) A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2. Virology 245(2): 353–359
72. Kondo K et al (2007) Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology 358(2):266–272
73. Alphs HH et al (2008) Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc Natl Acad Sci U S A 105(15):5850–5855
74. Day PM et al (2007) Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 81(16):8784–8792
75. Campos SK, Ozbun MA (2009) Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfi de bond and are critical for infectivity in human keratinocytes. PLoS One 4(2):e4463
76. Gambhira R et al (2009) Role of L2 cysteines in papillomavirus infection and neutralization. Virol J 6:176
77. Conway MJ et al (2011) Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes. PLoS One 6(2): e16405
78. Casini GL et al (2004) In vitro papillomavirus capsid assembly analyzed by light scattering. Virology 325(2):320–327
79. Nieto K et al (2012) Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate. PLoS One 7(6):e39741
80. Meyers C et al (2002) Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera. J Virol 76(10): 4723–4733